Adjuvant capecitabine treatment for stage III colon cancer in Japanese patients (KSCC0803). Phase II trial of cetuximab plus irinotecan for FOLFOX and FOLFIRI-refractory patients with EGFR-positive ...
Impact of PIK3CA mutations and p95HER2 expression on the outcome of HER2-positive metastatic breast cancer patients treated with a trastuzumab-based therapy.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈